Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients

被引:16
作者
Quast, Anne-Floor B. E. [1 ]
Baalman, Sarah W. E. [1 ]
Van der Stuijt, Willeke [1 ]
Wilde, Arthur A. M. [1 ]
Knops, Reinoud E. [1 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Amsterdam Cardiovasc Sci, Dept Clin & Expt Cardiol,Heart Ctr, Meibergdreef 9, Amsterdam, Netherlands
关键词
conversion testing; defibrillation threshold testing; implant technique; induced arrhythmias; subcutaneous ICD; CARDIOVERTER-DEFIBRILLATOR; SAFETY; EFFICACY; OUTCOMES;
D O I
10.1111/jce.14171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Since the introduction of the subcutaneous implantable-defibrillator (S-ICD) knowledge of factors elevating the defibrillation threshold (DFT), have increased. Optimal device positioning most likely results in a decrease in DFT. The PRAETORIAN score is a tool to systematically evaluate S-ICD implant position and predict conversion success by estimating the DFT on a chest X-ray. The objective of this study is to determine DFT in de novo S-ICD patients. Methods De novo S-ICD patients were enrolled with DFT testing using a single 30 J shock or a prespecified step-down protocol. Chest X-rays were obtained and implant position was evaluated using the PRAETORIAN score. Results Fifteen patients, age 47 (+/- 18) years and body mass index (BMI) 25(+/- 3) kg/m(2), underwent conversion testing with a single 30 J shock. Fourteen patients (93%) converted successfully. Implant position was optimal in all patients, PRAETORIAN score of 30 (100%). Twelve patients were available for analysis in the step-down DFT cohort, age 46 years (+/- 15), left ventricular ejection fraction 50% (+/- 15%) and a median BMI of 25.7 kg/m(2) (range 23.8-29.1 kg/m(2)). No complications occurred during DFT testing. Mean DFT was 29 J (+/- 12 J). Time to shock was 11 seconds (+/- 2 seconds) for a 20 J shock compared with 17 seconds in case of a 70 J shock output. Nearly all patients were implanted with optimal device positioning with the lowest possible PRAETORIAN score of 30 (92%). Conclusion DFT in S-ICD patients with optimal device positioning is lower than previously reported. Conversion testing using a low shock output reduced time to therapy by 6 seconds on average.
引用
收藏
页码:2441 / 2447
页数:7
相关论文
共 20 条
[1]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[2]   An Entirely Subcutaneous Implantable Cardioverter-Defibrillator [J].
Bardy, Gust H. ;
Smith, Warren M. ;
Hood, Margaret A. ;
Crozier, Ian G. ;
Melton, Iain C. ;
Jordaens, Luc ;
Theuns, Dominic ;
Park, Robert E. ;
Wright, David J. ;
Connelly, Derek T. ;
Fynn, Simon P. ;
Murgatroyd, Francis D. ;
Sperzel, Johannes ;
Neuzner, Joerg ;
Spitzer, Stefan G. ;
Ardashev, Andrey V. ;
Oduro, Amo ;
Boersma, Lucas ;
Maass, Alexander H. ;
Van Gelder, Isabelle C. ;
Wilde, Arthur A. ;
van Dessel, Pascal F. ;
Knops, Reinoud E. ;
Barr, Craig S. ;
Lupo, Pierpaolo ;
Cappato, Riccardo ;
Grace, Andrew A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :36-44
[3]   The defibrillation safety margin of patients receiving ICDs: A matter of definition [J].
Barold, SS ;
Herweg, B ;
Curtis, AB .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09) :881-882
[4]   Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry The EFFORTLESS Study [J].
Boersma, Lucas ;
Barr, Craig ;
Knops, Reinoud ;
Theuns, Dominic ;
Eckardt, Lars ;
Neuzil, Petr ;
Scholten, Marcoen ;
Hood, Margaret ;
Kuschyk, Juergen ;
Jones, Paul ;
Duffy, Elizabeth ;
Husby, Michael ;
Stein, Kenneth ;
Lambiase, Pier D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) :830-841
[5]  
BostonScientific, 2016, US MAN EMBLEM S ICD
[6]   Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry [J].
Burke, Martin C. ;
Gold, Michael R. ;
Knight, Bradley P. ;
Barr, Craig S. ;
Theuns, Dominic A. M. J. ;
Boersma, Lucas V. A. ;
Knops, Reinoud E. ;
Weiss, Raul ;
Leon, Angel R. ;
Herre, John M. ;
Husby, Michael ;
Stein, Kenneth M. ;
Lambiase, Pier D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (16) :1605-1615
[7]   Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: Implications for a total subcutaneous implantable defibrillator [J].
Burke, MC ;
Coman, JA ;
Cates, AW ;
Lindstrom, CC ;
Sandler, DA ;
Kim, SS ;
Knight, BP .
HEART RHYTHM, 2005, 2 (12) :1332-1338
[8]   Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States [J].
Friedman, Daniel J. ;
Parzynski, Craig S. ;
Varosy, Paul D. ;
Prutkin, Jordan M. ;
Patton, Kristen K. ;
Mithani, Ali ;
Russo, Andrea M. ;
Curtis, Jeptha P. ;
Al-Khatib, Sana M. .
JAMA CARDIOLOGY, 2016, 1 (08) :900-911
[9]   Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue? [J].
Frommeyer, Gerrit ;
Zumhagen, Sven ;
Dechering, Dirk G. ;
Larbig, Robert ;
Bettin, Markus ;
Loeher, Andreas ;
Koebe, Julia ;
Reinke, Florian ;
Eckardt, Lars .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (03)
[10]  
Gold MR, 2017, HEART RHYTHM, V14, P634, DOI [10.1016/j.hrthm.2017.05.016, 10.1016/j.hrthm.2017.03.026]